WILSON TROY EDWARD — SEC insider filings

SEC reporting owner CIK 1589597. 46 insider filings on record with FilingPulse; latest filed 2026-11-17.

Transaction summary — filings shown

Covers all 46 filings on record, filed 2020-08-19 to 2026-11-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Kura Oncology, Inc. (KURA)President and CEO, Director249 legs · 700,000 sh · $6,073,87620 legs · 699,271 sh · $18,905,93754
Avidity Biosciences, Inc. (RNAM)Director10—8 legs · 124,554 sh · $5,752,43023
PUMA BIOTECHNOLOGY, INC. (PBYI)Director11—7 legs · 134,206 sh · $707,5436
Atrium Therapeutics, Inc. (RNA)Director1——1

Insider filings — WILSON TROY EDWARD

FiledFormIssuerReported transactionsSource
2026-11-174/AKura Oncology, Inc. (KURA)Purchase (P): 98,881 @ $7.63 · Purchase (P): 101,119 @ $7.42EDGAR
2026-11-164Kura Oncology, Inc. (KURA)Purchase (P): 98,881 @ $7.63 · Purchase (P): 101,119 @ $7.42EDGAR
2026-09-164PUMA BIOTECHNOLOGY, INC. (PBYI)Sale (S): 5,000 @ $9.10EDGAR
2026-08-244Kura Oncology, Inc. (KURA)Purchase (P): 100,000 @ $12.39EDGAR
2026-08-174Kura Oncology, Inc. (KURA)Purchase (P): 100,000 @ $11.12EDGAR
2026-06-154PUMA BIOTECHNOLOGY, INC. (PBYI)Grant/award (A): 27,000 @ $0 · Sale (S): 10,800 @ $7.20EDGAR
2026-03-254Kura Oncology, Inc. (KURA)Option exercise (M): 6,103 @ $6.15 · Option exercise (M): 6,103 (derivative) @ $0EDGAR
2026-03-024Atrium Therapeutics, Inc. (RNA)Grant/award (A): 20,000 (derivative) @ $0EDGAR
2026-02-274Avidity Biosciences, Inc. (RNAM)Disposition to issuer (D): 65,091 · Disposition to issuer (D): 13,711 · Disposition to issuer (D): 10,034 (derivative) · Disposition to issuer (D): 13,489 (derivative) · Disposition to issuer (D): 15,000 (derivative)EDGAR
2026-01-064Kura Oncology, Inc. (KURA)Grant/award (A): 1,120,000 (derivative) @ $0EDGAR
2025-11-144Kura Oncology, Inc. (KURA)Grant/award (A): 182,500 @ $0EDGAR
2025-09-294Kura Oncology, Inc. (KURA)Grant/award (A): 182,500 @ $0 · Sale (S): 36,615 @ $8.94EDGAR
2025-09-094Kura Oncology, Inc. (KURA)Purchase (P): 50,000 @ $8.20EDGAR
2025-09-094Avidity Biosciences, Inc. (RNA)Option exercise (M): 14,500 @ $12.48 · Sale (S): 14,500 @ $50 · Sale (S): 15,000 @ $50 · Option exercise (M): 14,500 (derivative) @ $0EDGAR
2025-08-144Kura Oncology, Inc. (KURA)Purchase (P): 36,506 @ $5.85 · Purchase (P): 13,494 @ $6.64EDGAR
2025-08-084Avidity Biosciences, Inc. (RNA)Option exercise (M): 22,000 @ $12.03 · Sale (S): 22,000 @ $45 · Option exercise (M): 7,500 @ $12.48 · Sale (S): 7,500 @ $45 · Sale (S): 15,000 @ $45 · Sale (S): 15,000 @ $45 · +4 moreEDGAR
2025-06-174PUMA BIOTECHNOLOGY, INC. (PBYI)Sale (S): 10,800 @ $3.40EDGAR
2025-06-134PUMA BIOTECHNOLOGY, INC. (PBYI)Grant/award (A): 27,000 @ $0EDGAR
2025-06-124Avidity Biosciences, Inc. (RNA)Grant/award (A): 6,692 @ $0 · Grant/award (A): 10,034 (derivative) @ $0EDGAR
2025-01-064Kura Oncology, Inc. (KURA)Grant/award (A): 625,000 (derivative) @ $0EDGAR
2024-06-214PUMA BIOTECHNOLOGY, INC. (PBYI)Grant/award (A): 27,000 @ $0EDGAR
2024-06-174PUMA BIOTECHNOLOGY, INC. (PBYI)Sale (S): 27,000 @ $3.33EDGAR
2024-06-144Avidity Biosciences, Inc. (RNA)Grant/award (A): 13,489 (derivative) @ $0EDGAR
2024-01-264Kura Oncology, Inc. (KURA)Option exercise (M): 6,945 @ $4.80 · Sale (S): 6,945 @ $20.23 · Option exercise (M): 84,107 @ $6.15 · Sale (S): 84,107 @ $20.23EDGAR
2024-01-044Kura Oncology, Inc. (KURA)Grant/award (A): 560,000 (derivative) @ $0EDGAR
2023-12-144Avidity Biosciences, Inc. (RNA)Other (J): 300,000 @ $0 · Other (J): 300,000 @ $0 · Other (J): 250,000 @ $0 · Other (J): 250,000 @ $0EDGAR
2023-12-114Kura Oncology, Inc. (KURA)Gift (G): 2,000 @ $0 · Gift (G): 1,000 @ $0EDGAR
2023-06-204Avidity Biosciences, Inc. (RNA)Grant/award (A): 22,000 (derivative) @ $0EDGAR
2023-06-154PUMA BIOTECHNOLOGY, INC. (PBYI)Sale (S): 27,000 @ $3.45 · Grant/award (A): 27,000 @ $0EDGAR
2023-06-024Kura Oncology, Inc. (KURA)Other (J): 8,394 @ $0 · Other (J): 8,394 @ $0 · Other (J): 41,318 @ $0 · Other (J): 212,500 @ $0 · Other (J): 300,000 @ $0 · Other (J): 300,000 @ $0 · +2 moreEDGAR
2023-02-214Kura Oncology, Inc. (KURA)Other (J): 468,297 @ $0 · Other (J): 17,708 @ $0 · Other (J): 41,318 @ $0 · Other (J): 41,318 @ $0 · Other (J): 1,084,300 @ $0 · Other (J): 1,084,300 @ $0 · +2 moreEDGAR
2022-06-214PUMA BIOTECHNOLOGY, INC. (PBYI)Sale (S): 27,858 @ $2.58EDGAR
2022-06-174Avidity Biosciences, Inc. (RNA)Grant/award (A): 22,000 (derivative) @ $0EDGAR
2022-06-164PUMA BIOTECHNOLOGY, INC. (PBYI)Grant/award (A): 27,000 @ $0EDGAR
2022-01-284Kura Oncology, Inc. (KURA)Grant/award (A): 495,000 (derivative) @ $0EDGAR
2021-06-174PUMA BIOTECHNOLOGY, INC. (PBYI)Grant/award (A): 27,858 @ $0EDGAR
2021-06-164Avidity Biosciences, Inc. (RNA)Grant/award (A): 15,000 (derivative) @ $0EDGAR
2021-06-114PUMA BIOTECHNOLOGY, INC. (PBYI)Sale (S): 25,748 @ $11.36EDGAR
2021-01-284Kura Oncology, Inc. (KURA)Other (J): 175,000 @ $0 · Grant/award (A): 366,500 (derivative) @ $0EDGAR
2020-12-284Avidity Biosciences, Inc. (RNA)Other (J): 100,000 @ $0 · Other (J): 100,000 @ $0EDGAR
2020-12-024Kura Oncology, Inc. (KURA)Option exercise (M): 11,855 @ $6.15 · Option exercise (M): 11,855 (derivative) @ $0EDGAR
2020-10-084Kura Oncology, Inc. (KURA)Sale (S): 100 @ $32 · Sale (S): 99,900 @ $32 · Sale (S): 106,736 @ $34 · Option exercise (M): 4,586 @ $6.15 · Sale (S): 4,586 @ $34 · Option exercise (M): 50,370 @ $6.15 · +3 moreEDGAR
2020-09-154Kura Oncology, Inc. (KURA)Option exercise (M): 17,926 @ $6.15 · Sale (S): 17,926 @ $28 · Sale (S): 485 @ $28 · Sale (S): 98,490 @ $28.82 · Option exercise (M): 17,926 (derivative) @ $0EDGAR
2020-09-104Kura Oncology, Inc. (KURA)Sale (S): 50,000 @ $26 · Sale (S): 1,025 @ $28 · Option exercise (M): 37,030 @ $6.15 · Sale (S): 37,030 @ $28 · Option exercise (M): 37,030 (derivative) @ $0EDGAR
2020-08-264Kura Oncology, Inc. (KURA)Option exercise (M): 6,568 @ $4.80 · Sale (S): 6,568 @ $22.04 · Option exercise (M): 22,838 @ $6.15 · Option exercise (M): 215 @ $4.80 · Sale (S): 23,053 @ $22.37 · Option exercise (M): 6,568 (derivative) @ $0 · +2 moreEDGAR
2020-08-194Kura Oncology, Inc. (KURA)Gift (G): 26,041 @ $0 · Gift (G): 26,041 @ $0 · Sale (S): 50,000 @ $22 · Option exercise (M): 12,901 @ $4.80 · Sale (S): 12,901 @ $22.00 · Option exercise (M): 521 @ $4.80 · +6 moreEDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-18 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1589597 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs